Improving Function, Quality of Life, Glycemia in Diabetics With Dementia

Summary

The primary purpose of this study is to determine if the study medication Methylphenidate (Ritalin) will improve subject's blood-sugar control by improving their motivation more than placebo. The secondary objectives of the study are to determine if daily functioning and quality of life improves with methylphenidate treatment.

Timeline

Start

2008-11-18

Primary completion

2011-12-20

Completion

2011-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “No Subjects enrolled”

Drugs

Indications